Elekta B Shs (EKTAF) 6.5400 $EKTAF
Elekta reports proposals by nomination committee on board of directors for AGM 2015
M2 - Wed Jul 01, 6:01AM CDT
Human care company Elekta AB (STO:EKTA-B.ST) announced today that the nomination committee of its board of directors has proposed that the 2015 Annual General Meeting re-elect board members Laurent Leksell, Luciano Cattani, Siaou-Sze Lien, Wolfgang Reim, Jan Secher, Birgitta Stymne Goransson and Tomas Puusepp.
Elekta Nomination Committee's Proposed Board of Directors for the 2015 Annual General Meeting
Business Wire - Wed Jul 01, 12:44AM CDT
Regulatory News:
Elekta AB: Short Company Intro
Felix F. Frenzel - Seeking Alpha - Tue Jun 23, 6:24AM CDT
This week's post is an introduction of a (well known) Swedish company. After several guidance adjustments, the company has disappointed some investors and the shares have dropped significantly; potentially, by too far? We will try to give an overview...
VAR: 86.80 (+1.82)
The Weekender
Aviate - at Seeking Alpha - Sun Jun 14, 5:17AM CDT
Got Europe? Got European Equities? We are all acutely aware of the performance YTD of sovereign bonds vs. equities. European Sovereign Bonds total return -2.7% vs. the SXXP Total Return +16.7%. Going back 2 years, the chart is just as ugly. BUT,...
DEO: 118.94 (+3.94), TMUS: 39.03 (+0.26), LYG: 5.28 (+0.12), GSK: 42.45 (+0.65), NVO: 57.68 (+2.91), PSO: 19.11 (+0.56), BT: 70.82 (+1.96), S: 3.78 (-0.12), SHPG: 250.34 (+7.35), BP: 39.90 (+0.77), RIO: 39.14 (+0.61), AAPL: 123.28 (+3.21), HSBC: 43.87 (+0.85), FCAU: 14.47 (+0.53), VOD: 36.46 (+1.07), DISH: 68.81 (+1.80), ARMH: 47.42 (+0.06), BABA: 80.30 (+1.26)
Elekta's Leksell Gamma Knife Icon system used for the first time in Asia in Korean hospital
M2 - Thu Jun 11, 5:44AM CDT
Elekta AB (STO:EKTAB) announced on Wednesday that it has signed a contract with an advanced hospital in Korea, Samsung Medical Centre (SMC) in Seoul, to deliver the first Leksell Gamma Knife Icon to Asia.
Elekta announces CE mark for its Leksell Gamma Knife Icon
M2 - Wed Jun 10, 4:20AM CDT
Elekta AB (STO:EKTAB.ST) announced on Tuesday that it has CE marked its Leksell Gamma Knife Icon precision radiosurgery system, making this latest generation Leksell Gamma Knife platform available in the European market.
Russian Medical Devices Market: Investment Opportunities, Growth Forecasts by Care Areas and Local Competitive Landscape 2015-2018
M2 - Mon Jun 08, 3:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pfk355/russian_medical) has announced the addition of the "Russian Medical Devices Market: Investment Opportunities, Growth Forecasts by Care Areas and Local Competitive Landscape (2015-2018)" report to their offering. With over 77% of the medical device consumption being dependent on imports, Russia has been looking to reduce its reliance on foreign manufacturers. As the government adopts pro-domestic manufacturer policies especially for public hospital tenders, there would be additional ramifications for multinational firms. Localization strategies adopted by MNCs for production of medical devices within Russia may also be impacted by the current economic downturn. With over 1000 local manufacturers of medical devices, the Russian market for medical devices is fragmented for various product categories. Certain medical device manufacturers are looking to counter the current import restrictions by weighing localization strategies. Several global manufacturers have been looking to improve market penetration through strategic partnership with local dealers and small device manufactures. Key Features - Who are the key global manufacturers of medical devices operating in Russia? - Who are the key local medical device manufacturers? - What are the key hospital dynamics and new hospital launches in 2014-2015? - What are the various healthcare policies from 2014-2015 that are likely to impact the medical device market in Russia? Key Topics Covered: Chapter 1: INTRODUCTION Chapter 2: EXECUTIVE SUMMARY Chapter 3: BUSINESS ENVIRONMENT IN RUSSIA Chapter 4: RUSSIAN HEALTHCARE AND HOSPITAL INDUSTRY IN 2014-2015 Chapter 5: MEDICAL DEVICE MARKET IN RUSSIA: 2014-2018 Chapter 6: COMPETITIVE LANDSCAPE IN RUSSIA Chapter 7: KEY HOSPITAL AND MEDICAL DEVICE NEWS (2014-2015) Companies Mentioned - AKC - Aksi Group - Alcom Medica - Altonika - Amico - Association of Medicine and Analytics (AMA) - Astrocard Meditek Ltd - Axion - B.Braun Melsungen AG - Bayer Healthcare AG - Becton, Dickinson and Company - Conmet Holding - ELAMED-JSC Yelatma Instrument making enterprise - Electron - Elekta AB - Eltech-Med - Fresenius SE & Co. KGaA - GE Healthcare - Intersan Plus - JSC SPF Bioss - Johnson & Johnson Services, Inc. - Kreyt - MSPA Endomedium - Medprom - Medtronic plc - Microsurgical instruments - Minimax - OOO Petr Telegin - Optimed - Orion Medic - Rateks - Royal Philips (Koninklijke Philips N.V.) - Siemens Healthcare - Volo - Zdravmedtech (ZMT) For more information visit http://www.researchandmarkets.com/research/pf...an_medical
JNJ: 99.53 (+1.13), MDT: 74.37 (+1.28)
Elekta reorganises company and changes executive management team
M2 - Wed Jun 03, 4:05AM CDT
Human care company Elekta AB (STO:EKTAB.ST) on Tuesday announced a reorganisation of the company to adapt to current market conditions and improve growth, profitability and efficiency, as well as changes in its executive management team.
Elekta's (EKTAF) CEO Tomas Puusepp on Q4 2014/15 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Jun 02, 1:17PM CDT
Global Oncology Information System Market 2015 by Software, Application, End User - Forecasts to 2019
M2 - Mon May 25, 5:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/68zb85/oncology) has announced the addition of the "Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital, Government Institution, & Research Center) - Global Forecasts to 2019" report to their offering. The global oncology information system market is estimated to grow at a CAGR of 8.5% from 2014 to 2019 Although mature markets such as the U.S., the U.K., and Germany hold larger shares in the oncology information system market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 11.5% in the next five years. Factors such as increasing government initiatives for modernization of healthcare infrastructure, growing patient population, and rising focus of international and domestic players in the Asia-Pacific region are propelling growth in this market. Growth of the oncology information system market is driven by factors such as rapidly aging population, rising number of cancer cases, and increasing focus on the development of technologically advanced OIS across the globe. However, factors such as high maintenance and service expenses, and dearth of healthcare IT professionals are restraining the growth of this market. Moreover, emerging markets (such as China and India), strategic acquisitions, and multi-year contracts and agreements offer significant opportunities for growth of the oncology information system market. In this report, the global oncology information system market has been segmented on the basis of product and services [software (patient information systems and treatment planning systems) and professional services (consulting, implementation, post-sale & maintenance, and training)], application (medical, radiation, and surgical oncology), and end user (hospitals & physician's offices, governmental institutions, and research centers). The patient information systems segment is estimated to account for the largest share of the global oncology information system market in 2014, followed by the treatment planning systems market. Factors such as new product launches, technological advancements, and increasing adoption of OIS for cancer care are stimulating the growth of the patient information systems market. Geographically, North America (comprising the U.S. and Canada) commands the largest share of 42.8% of the global oncology information system market in 2014, followed by Europe. The North American oncology information system market is primarily driven by various factors such as growth in aging population, high prevalence of cancer cases, and high adoption rate of technologically advanced devices in North American countries. However, unfavorable healthcare reforms in the U.S. constraints the growth of the oncology information system market in this region. The global oncology information system market is highly competitive, with a large number of global and local players. As of 2013, the global oncology information system market was dominated by Elekta AB (Sweden) and Varian Medical Systems, Inc. (U.S.) which together accounted for -80% of the market. Agreements and partnerships; development of technologically advanced OIS; and strategic acquisitions are major strategies adopted by the market players to achieve growth in the oncology information system market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Oncology Information System Market, By Products and Services 8 Oncology Information System Market, By Application 9 Oncology Information System Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Accuray Incorporated - Altos Solutions, Inc. - Cerner Corporation - Elekta AB - Epic Systems Corporation - Koninklijke Philips N.V. - Mckesson Corporation - Varian Medical Systems, Inc. For more information visit http://www.researchandmarkets.com/research/68zb85/oncology
VAR: 86.80 (+1.82), MDSY: 1.62 (-0.18), ARAY: 6.74 (+0.03), CERN: 69.92 (+1.45)
Global Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
M2 - Thu May 14, 8:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lhrlvh/surgical_robots) has announced the addition of Wintergreen Research, Inc's new report "Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021" to their offering. Surgical robot device markets at $3.2 billion in 2014 are anticipated to reach $20 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds. The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players' success, challenges, and strategies in each segment and subsegment. The reports cover markets for: medical specialties and sub-specialties. The new study Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021 has 553 pages, 216 tables and figures. Worldwide surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and decrease the number of ports needed for minimally invasive surgery. Intuitive Surgical has market leadership position, advanced technology, an impressive installed base and a well trained group of surgeons able to manage the robots. Patients fare better when the surgery is done by surgical robots. The documentation of improvements in care delivery, the ability to ensure better outcomes from surgery promise that surgical robotics is a strong growth market. Intuitive Surgical will be difficult to dislodge, its dominant position is based on technological excellence that keeps being improved and competitors have a difficult time catching up, much less improving on the Intuitive Surgical technology. Other leading competitors will emerge and the group of several surgical robotic companies will collectively have enough marketing dollars and enough marketing clout to drive replacement of all open surgery. Robotic surgery is positioned to become the standard of care. Intuitive Surgical has achieved market saturation in colorectal surgery in the US, it will work on increasing its presence in other surgical market sectors. The leading robotic surgical companies are poised to grow through acquisition, purchasing smaller companies that have developed as specialized product and gained FDA approval. As detailed in the market research study there are a lot of those in every medical specialty and more to come. Key Topics Covered: 1. Surgical Robots Market Description and Market Dynamics 2. Surgical Robot Market Shares and Forecasts 3. Surgical Robots Product Description 4. Medical Robot Technology 5. Surgical Robots Company Description Companies Mentioned - AVRA Surgical - Accel Spine - Accuray - Aesynt / Health Robotics - Alliance Spine - Amedica - Elekta AB - Freehand 2010 - Globus Medical - Hansen Medical - Healthcare Robotics Lab - Intuitive Surgical - Johnson and Johnson / DePuy Synthes - Medrobotics - Medtronic - NLT Spine - NuVasive - Otto Bock HealthCare - Precision Spine - RTI Biologics / Pioneer Surgical Technology - Restoration Robotics - SI-BONE 503 - Spinal Elements - SpineGuard - Spineart - Spineology - Stryker - Think Surgical - Titan Medical - TranS1 - UC Berkeley - Varian Medical Systems. - Vecna Robotics - Victrex plc / Invibio - Vycor For more information visit http://www.researchandmarkets.com/research/lh...cal_robots Source: Wintergreen Research, Inc
ISRG: 487.87 (+6.40), JNJ: 99.53 (+1.13), RTIX: 6.55 (+0.29), VAR: 86.80 (+1.82), MDT: 74.37 (+1.28), HNSN: 0.90 (+0.02), GMED: 25.39 (+0.42)
ELEKTA's (EKTAF) CEO Tomas Puusepp on Q4 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed May 13, 4:05PM CDT
Elekta introduces new Leksell Gamma Knife for brain tumours
M2 - Mon Apr 27, 3:22AM CDT
Human care company Elekta AB (STO:EKTAB.ST) on Friday unveiled the new Leksell Gamma Knife Icon at the 3rd ESTRO Forum in Barcelona.
Global Oncology Ablation Market Outlook 2014-2020
M2 - Tue Apr 14, 9:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ksr667/global_oncology) has announced the addition of the "Global Oncology Ablation Market Outlook: 2014-2020" report to their offering. The research report titled Global Oncology Ablation Market Outlook: 2014-2020 provides in-depth analysis of oncology ablation market in four major geographies. The report also emphasizes on the current trends in oncology ablation, market size, market share, recent developments, and forecasts till 2020. Oncology Ablation is the minimal invasive treatment that is used to destroy or inactive the cancer cells and tumors. The market for oncology ablation is on the rise due to increasing number of cancer diagnosis and high acceptance rate among the cancer community across the world. Over the traditional treatment, oncology ablation has many advantages as it is minimal invasive treatment that makes the recovery easy and quick; also it provides relief to patients who are reluctant to go for a surgery. Image guided ablation treatments promises the accuracy in destruction of tumor cells without damaging the uninfected cells. The study offers a comprehensive analysis of oncology ablation market with respect to various technologies and type of cancer. The technologies analyzed in this report are radiofrequency ablation, microwave ablation, cryoablation, ethanol ablation, irreversible electroporesis (IRE), light (laser ablation), and ultrasound ablation; whereas, the cancer types analyzed in the report are lung cancer, liver cancer, breast cancer, kidney cancer, colorectal cancer and prostate cancer. Comprehensive geographical analysis of the oncology ablation is provided by segmenting the global market on the basis of major continents, namely, North America, Europe, Asia Pacific, and RoW (Rest of the World) which are further analyzed at a country level. The report offers meticulous analysis of market dynamics, burning issues, and technological landscape of the global oncology ablation market. The report provides the competitive landscape of the major players in this market with detailed analysis of their product portfolio, financials, and recent developments. Key Topics Covered: 1 Introduction to Global Oncology Ablation Market 2 Executive Summary 3 Market Insights 4 Global Oncology Ablation Market, By Technology 5 Global Oncology Ablation Market, By Type Of Cancer 6 Oncology Ablation Market, By Geography 7 Competitive Landscape- Global Oncology Ablation Market 8 Company Profiles - APRO KOREA - Accuray Inc. - AngioDynamics - BSD Medical - Boston Scientific - Celon AG (Olympus) - Covidien - Elekta AB - Galil Medical - HealthTronics Inc. - MedWaves Incorporated - Misonix Inc. - NeuWave Medical - RF Medical Co. Ltd - STARMed Co. Ltd - SonaCare Medical - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/ks...l_oncology
BSX: 17.60 (+0.15), VAR: 86.80 (+1.82), MSON: 8.95 (-0.03), BSDM: 0.62 (+0.13), ARAY: 6.74 (+0.03)
Elekta to acquire assets of AEESA, its Mexican distributor
M2 - Wed Apr 01, 3:53AM CDT
Human care company Elekta AB (STO:EKTAB.ST) announced today the signing of an agreement to acquire the service business as well as personnel of Mexican distributor, Asesores Electronicos Especializados S.A. de C.V (AEESA).
Elekta announces departure of EVP Corporate Strategy
M2 - Wed Mar 18, 6:41AM CDT
Human care company Elekta AB (STO:EKTAB.ST) announced on Wednesday that Asa Hedin, executive vice president Corporate Strategy, will leave the company, effective 30 March 2015, to take up another opportunity.
Elekta completes acquisition of RTA in Poland
M2 - Tue Mar 17, 5:36AM CDT
Human care company Elekta AB (STO:EKTAB) announced on Tuesday that it has completed its acquisition of Polish distributor RTA.
Elekta reports proposals by nomination committee on board of directors for AGM 2015
M2 - Wed Jul 01, 6:01AM CDT
Human care company Elekta AB (STO:EKTA-B.ST) announced today that the nomination committee of its board of directors has proposed that the 2015 Annual General Meeting re-elect board members Laurent Leksell, Luciano Cattani, Siaou-Sze Lien, Wolfgang Reim, Jan Secher, Birgitta Stymne Goransson and Tomas Puusepp.
Elekta Nomination Committee's Proposed Board of Directors for the 2015 Annual General Meeting
Business Wire - Wed Jul 01, 12:44AM CDT
Regulatory News:
Elekta AB: Short Company Intro
Felix F. Frenzel - Seeking Alpha - Tue Jun 23, 6:24AM CDT
This week's post is an introduction of a (well known) Swedish company. After several guidance adjustments, the company has disappointed some investors and the shares have dropped significantly; potentially, by too far? We will try to give an overview...
VAR: 86.80 (+1.82)
The Weekender
Aviate - at Seeking Alpha - Sun Jun 14, 5:17AM CDT
Got Europe? Got European Equities? We are all acutely aware of the performance YTD of sovereign bonds vs. equities. European Sovereign Bonds total return -2.7% vs. the SXXP Total Return +16.7%. Going back 2 years, the chart is just as ugly. BUT,...
DEO: 118.94 (+3.94), TMUS: 39.03 (+0.26), LYG: 5.28 (+0.12), GSK: 42.45 (+0.65), NVO: 57.68 (+2.91), PSO: 19.11 (+0.56), BT: 70.82 (+1.96), S: 3.78 (-0.12), SHPG: 250.34 (+7.35), BP: 39.90 (+0.77), RIO: 39.14 (+0.61), AAPL: 123.28 (+3.21), HSBC: 43.87 (+0.85), FCAU: 14.47 (+0.53), VOD: 36.46 (+1.07), DISH: 68.81 (+1.80), ARMH: 47.42 (+0.06), BABA: 80.30 (+1.26)
Elekta's Leksell Gamma Knife Icon system used for the first time in Asia in Korean hospital
M2 - Thu Jun 11, 5:44AM CDT
Elekta AB (STO:EKTAB) announced on Wednesday that it has signed a contract with an advanced hospital in Korea, Samsung Medical Centre (SMC) in Seoul, to deliver the first Leksell Gamma Knife Icon to Asia.
Elekta announces CE mark for its Leksell Gamma Knife Icon
M2 - Wed Jun 10, 4:20AM CDT
Elekta AB (STO:EKTAB.ST) announced on Tuesday that it has CE marked its Leksell Gamma Knife Icon precision radiosurgery system, making this latest generation Leksell Gamma Knife platform available in the European market.
Russian Medical Devices Market: Investment Opportunities, Growth Forecasts by Care Areas and Local Competitive Landscape 2015-2018
M2 - Mon Jun 08, 3:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pfk355/russian_medical) has announced the addition of the "Russian Medical Devices Market: Investment Opportunities, Growth Forecasts by Care Areas and Local Competitive Landscape (2015-2018)" report to their offering. With over 77% of the medical device consumption being dependent on imports, Russia has been looking to reduce its reliance on foreign manufacturers. As the government adopts pro-domestic manufacturer policies especially for public hospital tenders, there would be additional ramifications for multinational firms. Localization strategies adopted by MNCs for production of medical devices within Russia may also be impacted by the current economic downturn. With over 1000 local manufacturers of medical devices, the Russian market for medical devices is fragmented for various product categories. Certain medical device manufacturers are looking to counter the current import restrictions by weighing localization strategies. Several global manufacturers have been looking to improve market penetration through strategic partnership with local dealers and small device manufactures. Key Features - Who are the key global manufacturers of medical devices operating in Russia? - Who are the key local medical device manufacturers? - What are the key hospital dynamics and new hospital launches in 2014-2015? - What are the various healthcare policies from 2014-2015 that are likely to impact the medical device market in Russia? Key Topics Covered: Chapter 1: INTRODUCTION Chapter 2: EXECUTIVE SUMMARY Chapter 3: BUSINESS ENVIRONMENT IN RUSSIA Chapter 4: RUSSIAN HEALTHCARE AND HOSPITAL INDUSTRY IN 2014-2015 Chapter 5: MEDICAL DEVICE MARKET IN RUSSIA: 2014-2018 Chapter 6: COMPETITIVE LANDSCAPE IN RUSSIA Chapter 7: KEY HOSPITAL AND MEDICAL DEVICE NEWS (2014-2015) Companies Mentioned - AKC - Aksi Group - Alcom Medica - Altonika - Amico - Association of Medicine and Analytics (AMA) - Astrocard Meditek Ltd - Axion - B.Braun Melsungen AG - Bayer Healthcare AG - Becton, Dickinson and Company - Conmet Holding - ELAMED-JSC Yelatma Instrument making enterprise - Electron - Elekta AB - Eltech-Med - Fresenius SE & Co. KGaA - GE Healthcare - Intersan Plus - JSC SPF Bioss - Johnson & Johnson Services, Inc. - Kreyt - MSPA Endomedium - Medprom - Medtronic plc - Microsurgical instruments - Minimax - OOO Petr Telegin - Optimed - Orion Medic - Rateks - Royal Philips (Koninklijke Philips N.V.) - Siemens Healthcare - Volo - Zdravmedtech (ZMT) For more information visit http://www.researchandmarkets.com/research/pf...an_medical
JNJ: 99.53 (+1.13), MDT: 74.37 (+1.28)
Elekta reorganises company and changes executive management team
M2 - Wed Jun 03, 4:05AM CDT
Human care company Elekta AB (STO:EKTAB.ST) on Tuesday announced a reorganisation of the company to adapt to current market conditions and improve growth, profitability and efficiency, as well as changes in its executive management team.
Elekta's (EKTAF) CEO Tomas Puusepp on Q4 2014/15 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Jun 02, 1:17PM CDT
Global Oncology Information System Market 2015 by Software, Application, End User - Forecasts to 2019
M2 - Mon May 25, 5:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/68zb85/oncology) has announced the addition of the "Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital, Government Institution, & Research Center) - Global Forecasts to 2019" report to their offering. The global oncology information system market is estimated to grow at a CAGR of 8.5% from 2014 to 2019 Although mature markets such as the U.S., the U.K., and Germany hold larger shares in the oncology information system market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 11.5% in the next five years. Factors such as increasing government initiatives for modernization of healthcare infrastructure, growing patient population, and rising focus of international and domestic players in the Asia-Pacific region are propelling growth in this market. Growth of the oncology information system market is driven by factors such as rapidly aging population, rising number of cancer cases, and increasing focus on the development of technologically advanced OIS across the globe. However, factors such as high maintenance and service expenses, and dearth of healthcare IT professionals are restraining the growth of this market. Moreover, emerging markets (such as China and India), strategic acquisitions, and multi-year contracts and agreements offer significant opportunities for growth of the oncology information system market. In this report, the global oncology information system market has been segmented on the basis of product and services [software (patient information systems and treatment planning systems) and professional services (consulting, implementation, post-sale & maintenance, and training)], application (medical, radiation, and surgical oncology), and end user (hospitals & physician's offices, governmental institutions, and research centers). The patient information systems segment is estimated to account for the largest share of the global oncology information system market in 2014, followed by the treatment planning systems market. Factors such as new product launches, technological advancements, and increasing adoption of OIS for cancer care are stimulating the growth of the patient information systems market. Geographically, North America (comprising the U.S. and Canada) commands the largest share of 42.8% of the global oncology information system market in 2014, followed by Europe. The North American oncology information system market is primarily driven by various factors such as growth in aging population, high prevalence of cancer cases, and high adoption rate of technologically advanced devices in North American countries. However, unfavorable healthcare reforms in the U.S. constraints the growth of the oncology information system market in this region. The global oncology information system market is highly competitive, with a large number of global and local players. As of 2013, the global oncology information system market was dominated by Elekta AB (Sweden) and Varian Medical Systems, Inc. (U.S.) which together accounted for -80% of the market. Agreements and partnerships; development of technologically advanced OIS; and strategic acquisitions are major strategies adopted by the market players to achieve growth in the oncology information system market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Oncology Information System Market, By Products and Services 8 Oncology Information System Market, By Application 9 Oncology Information System Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Accuray Incorporated - Altos Solutions, Inc. - Cerner Corporation - Elekta AB - Epic Systems Corporation - Koninklijke Philips N.V. - Mckesson Corporation - Varian Medical Systems, Inc. For more information visit http://www.researchandmarkets.com/research/68zb85/oncology
VAR: 86.80 (+1.82), MDSY: 1.62 (-0.18), ARAY: 6.74 (+0.03), CERN: 69.92 (+1.45)
Global Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
M2 - Thu May 14, 8:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lhrlvh/surgical_robots) has announced the addition of Wintergreen Research, Inc's new report "Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021" to their offering. Surgical robot device markets at $3.2 billion in 2014 are anticipated to reach $20 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds. The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players' success, challenges, and strategies in each segment and subsegment. The reports cover markets for: medical specialties and sub-specialties. The new study Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021 has 553 pages, 216 tables and figures. Worldwide surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and decrease the number of ports needed for minimally invasive surgery. Intuitive Surgical has market leadership position, advanced technology, an impressive installed base and a well trained group of surgeons able to manage the robots. Patients fare better when the surgery is done by surgical robots. The documentation of improvements in care delivery, the ability to ensure better outcomes from surgery promise that surgical robotics is a strong growth market. Intuitive Surgical will be difficult to dislodge, its dominant position is based on technological excellence that keeps being improved and competitors have a difficult time catching up, much less improving on the Intuitive Surgical technology. Other leading competitors will emerge and the group of several surgical robotic companies will collectively have enough marketing dollars and enough marketing clout to drive replacement of all open surgery. Robotic surgery is positioned to become the standard of care. Intuitive Surgical has achieved market saturation in colorectal surgery in the US, it will work on increasing its presence in other surgical market sectors. The leading robotic surgical companies are poised to grow through acquisition, purchasing smaller companies that have developed as specialized product and gained FDA approval. As detailed in the market research study there are a lot of those in every medical specialty and more to come. Key Topics Covered: 1. Surgical Robots Market Description and Market Dynamics 2. Surgical Robot Market Shares and Forecasts 3. Surgical Robots Product Description 4. Medical Robot Technology 5. Surgical Robots Company Description Companies Mentioned - AVRA Surgical - Accel Spine - Accuray - Aesynt / Health Robotics - Alliance Spine - Amedica - Elekta AB - Freehand 2010 - Globus Medical - Hansen Medical - Healthcare Robotics Lab - Intuitive Surgical - Johnson and Johnson / DePuy Synthes - Medrobotics - Medtronic - NLT Spine - NuVasive - Otto Bock HealthCare - Precision Spine - RTI Biologics / Pioneer Surgical Technology - Restoration Robotics - SI-BONE 503 - Spinal Elements - SpineGuard - Spineart - Spineology - Stryker - Think Surgical - Titan Medical - TranS1 - UC Berkeley - Varian Medical Systems. - Vecna Robotics - Victrex plc / Invibio - Vycor For more information visit http://www.researchandmarkets.com/research/lh...cal_robots Source: Wintergreen Research, Inc
ISRG: 487.87 (+6.40), JNJ: 99.53 (+1.13), RTIX: 6.55 (+0.29), VAR: 86.80 (+1.82), MDT: 74.37 (+1.28), HNSN: 0.90 (+0.02), GMED: 25.39 (+0.42)
ELEKTA's (EKTAF) CEO Tomas Puusepp on Q4 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed May 13, 4:05PM CDT
Elekta introduces new Leksell Gamma Knife for brain tumours
M2 - Mon Apr 27, 3:22AM CDT
Human care company Elekta AB (STO:EKTAB.ST) on Friday unveiled the new Leksell Gamma Knife Icon at the 3rd ESTRO Forum in Barcelona.
Global Oncology Ablation Market Outlook 2014-2020
M2 - Tue Apr 14, 9:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ksr667/global_oncology) has announced the addition of the "Global Oncology Ablation Market Outlook: 2014-2020" report to their offering. The research report titled Global Oncology Ablation Market Outlook: 2014-2020 provides in-depth analysis of oncology ablation market in four major geographies. The report also emphasizes on the current trends in oncology ablation, market size, market share, recent developments, and forecasts till 2020. Oncology Ablation is the minimal invasive treatment that is used to destroy or inactive the cancer cells and tumors. The market for oncology ablation is on the rise due to increasing number of cancer diagnosis and high acceptance rate among the cancer community across the world. Over the traditional treatment, oncology ablation has many advantages as it is minimal invasive treatment that makes the recovery easy and quick; also it provides relief to patients who are reluctant to go for a surgery. Image guided ablation treatments promises the accuracy in destruction of tumor cells without damaging the uninfected cells. The study offers a comprehensive analysis of oncology ablation market with respect to various technologies and type of cancer. The technologies analyzed in this report are radiofrequency ablation, microwave ablation, cryoablation, ethanol ablation, irreversible electroporesis (IRE), light (laser ablation), and ultrasound ablation; whereas, the cancer types analyzed in the report are lung cancer, liver cancer, breast cancer, kidney cancer, colorectal cancer and prostate cancer. Comprehensive geographical analysis of the oncology ablation is provided by segmenting the global market on the basis of major continents, namely, North America, Europe, Asia Pacific, and RoW (Rest of the World) which are further analyzed at a country level. The report offers meticulous analysis of market dynamics, burning issues, and technological landscape of the global oncology ablation market. The report provides the competitive landscape of the major players in this market with detailed analysis of their product portfolio, financials, and recent developments. Key Topics Covered: 1 Introduction to Global Oncology Ablation Market 2 Executive Summary 3 Market Insights 4 Global Oncology Ablation Market, By Technology 5 Global Oncology Ablation Market, By Type Of Cancer 6 Oncology Ablation Market, By Geography 7 Competitive Landscape- Global Oncology Ablation Market 8 Company Profiles - APRO KOREA - Accuray Inc. - AngioDynamics - BSD Medical - Boston Scientific - Celon AG (Olympus) - Covidien - Elekta AB - Galil Medical - HealthTronics Inc. - MedWaves Incorporated - Misonix Inc. - NeuWave Medical - RF Medical Co. Ltd - STARMed Co. Ltd - SonaCare Medical - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/ks...l_oncology
BSX: 17.60 (+0.15), VAR: 86.80 (+1.82), MSON: 8.95 (-0.03), BSDM: 0.62 (+0.13), ARAY: 6.74 (+0.03)
Elekta to acquire assets of AEESA, its Mexican distributor
M2 - Wed Apr 01, 3:53AM CDT
Human care company Elekta AB (STO:EKTAB.ST) announced today the signing of an agreement to acquire the service business as well as personnel of Mexican distributor, Asesores Electronicos Especializados S.A. de C.V (AEESA).
Elekta announces departure of EVP Corporate Strategy
M2 - Wed Mar 18, 6:41AM CDT
Human care company Elekta AB (STO:EKTAB.ST) announced on Wednesday that Asa Hedin, executive vice president Corporate Strategy, will leave the company, effective 30 March 2015, to take up another opportunity.
Elekta completes acquisition of RTA in Poland
M2 - Tue Mar 17, 5:36AM CDT
Human care company Elekta AB (STO:EKTAB) announced on Tuesday that it has completed its acquisition of Polish distributor RTA.
